downgrad reduc tough year ahead
mute sale margin miss expect earn
line driven lower corpor expens
mute guidanc slowdown end-market result
earn declin
downgrad reduc hold high valuat
cut target price
lacklustr perform mute guidanc sale
bbg consensu expect underli sale
grew driven growth autom
declin vs commerci residenti sale grew
vs guidanc driven underli sale growth
autom commerci residenti overal adj ep
guidanc y-o-i oper cash flow
guidanc impli convers
exclud discret non-cash tax benefit net incom manag initi
adj ep guidanc vs stand bbg consensu
organ sale growth
end-market slowdown trail three-month underli order growth moder
vs jun underl autom solut order
vs june slowdown autom order primarili due soft
upstream activ north america slower global discret market
underli order commerci residenti divis declin
vs jun due cooler weather north america slower condit
global profession tool cold chain market
ep guidanc difficult achiev even given mute guidanc
deterior end-market believ guidanc given
investor day februari difficult achiev even forecast
organ growth margin expans arriv ep
assum share repurchas
downgrad reduc cut tp stock trade
forward consensu earn premium histori
premium take decreas forward ep
appli target multipl previous impli
premium line five-year averag deriv
lower target price revis target price impli
downsid downgrad reduc hold rate
year
hsbc secur capit market india privat limit
global co-head industri research
employ non-u affili hsbc secur usa inc
registered/ qualifi pursuant finra regul
report must read disclosur analyst certif
disclosur appendix disclaim form part
issuer report hsbc secur capit
view hsbc global research
year
board member
employe cost revenu
ghg intens energi intens measur kg kwh respect revenu usd
note price close
year
base hsbc ep dilut
flow oper
flow invest
chang net debt
ratio growth per share analysi
year
cf operations/net debt
electricrel
emerson quarterli underli sale order growth trend
chang medium-term estim
adjust estim result guidanc outlook commentari
cut ep estim ep
driven organ sale growth almost flat flat segment margin share
repurchas
ep driven organ sale growth margin expans
share repurchas introduc ep driven
organ sale growth margin expans share repurchas bn
stock current trade forward consensu earn
premium ten-year averag emerson current trade premium
industri forward consensu earn much five-year
histor averag
emerson chang estim
flow oper
chang earlier est
valu emerson use target forward pe multipl vs
previous line movement peer group multipl impli premium
 line five-year averag roll forward
valuat horizon appli target multipl forward ep estim
previous arriv slightli lower target price
previous impli downsid current share price
given mute guidanc deterior end-market believ guidanc
given investor day februari difficult achiev even
downgrad reduc rate
upsid risk process market grow faster pace expect manag
abl off-set earn dilut integr new busi much effici manner
expect
